Extracts of a press release from Medicines and Healthcare products Regulatory Agency, titled MHRA issues new advice, concluding a possible link between COVID-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots, dated 07/04/2021.
Module 4 adduced:
• Pages 1, 4 on 22 January 2025